BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38671320)

  • 1. Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions.
    Purdue MP; Dutta D; Machiela MJ; Gorman BR; Winter T; Okuhara D; Cleland S; Ferreiro-Iglesias A; Scheet P; Liu A; Wu C; Antwi SO; Larkin J; Zequi SC; Sun M; Hikino K; Hajiran A; Lawson KA; Cárcano F; Blanchet O; Shuch B; Nepple KG; Margue G; Sundi D; Diver WR; Folgueira MAAK; van Bokhoven A; Neffa F; Brown KM; Hofmann JN; Rhee J; Yeager M; Cole NR; Hicks BD; Manning MR; Hutchinson AA; Rothman N; Huang WY; Linehan WM; Lori A; Ferragu M; Zidane-Marinnes M; Serrano SV; Magnabosco WJ; ; Vilas A; Decia R; Carusso F; Graham LS; Anderson K; Bilen MA; Arciero C; Pellegrin I; Ricard S; ; Scelo G; Banks RE; Vasudev NS; Soomro N; Stewart GD; Adeyoju A; Bromage S; Hrouda D; Gibbons N; Patel P; Sullivan M; Protheroe A; Nugent FI; Fournier MJ; Zhang X; Martin LJ; Komisarenko M; Eisen T; Cunningham SA; Connolly DC; Uzzo RG; Zaridze D; Mukeria A; Holcatova I; Hornakova A; Foretova L; Janout V; Mates D; Jinga V; Rascu S; Mijuskovic M; Savic S; Milosavljevic S; Gaborieau V; Abedi-Ardekani B; McKay J; Johansson M; Phouthavongsy L; Hayman L; Li J; Lungu I; Bezerra SM; Souza AG; Sares CTG; Reis RB; Gallucci FP; Cordeiro MD; Pomerantz M; Lee GM; Freedman ML; Jeong A; Greenberg SE; Sanchez A; Thompson RH; Sharma V; Thiel DD; Ball CT; Abreu D; Lam ET; Nahas WC; Master VA; Patel AV; Bernhard JC; Freedman ND; Bigot P; Reis RM; Colli LM; Finelli A; Manley BJ; Terao C; Choueiri TK; Carraro DM; Houlston R; Eckel-Passow JE; Abbosh PH; Ganna A; Brennan P; Gu J; Chanock SJ
    Nat Genet; 2024 May; 56(5):809-818. PubMed ID: 38671320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genome-wide association study of renal cell carcinoma among African Americans.
    Purdue MP; Ye Y; Wang Z; Colt JS; Schwartz KL; Davis FG; Rothman N; Chow WH; Wu X; Chanock SJ
    Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):209-14. PubMed ID: 24220910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The polymorphisms in the VHL and HIF1A genes are associated with the prognosis but not the development of renal cell carcinoma.
    Qin C; Cao Q; Ju X; Wang M; Meng X; Zhu J; Yan F; Li P; Ding Q; Chen J; Gu M; Zhang W; Yin C; Zhang Z
    Ann Oncol; 2012 Apr; 23(4):981-9. PubMed ID: 21778301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide association study identifies multiple risk loci for renal cell carcinoma.
    Scelo G; Purdue MP; Brown KM; Johansson M; Wang Z; Eckel-Passow JE; Ye Y; Hofmann JN; Choi J; Foll M; Gaborieau V; Machiela MJ; Colli LM; Li P; Sampson JN; Abedi-Ardekani B; Besse C; Blanche H; Boland A; Burdette L; Chabrier A; Durand G; Le Calvez-Kelm F; Prokhortchouk E; Robinot N; Skryabin KG; Wozniak MB; Yeager M; Basta-Jovanovic G; Dzamic Z; Foretova L; Holcatova I; Janout V; Mates D; Mukeriya A; Rascu S; Zaridze D; Bencko V; Cybulski C; Fabianova E; Jinga V; Lissowska J; Lubinski J; Navratilova M; Rudnai P; Szeszenia-Dabrowska N; Benhamou S; Cancel-Tassin G; Cussenot O; Baglietto L; Boeing H; Khaw KT; Weiderpass E; Ljungberg B; Sitaram RT; Bruinsma F; Jordan SJ; Severi G; Winship I; Hveem K; Vatten LJ; Fletcher T; Koppova K; Larsson SC; Wolk A; Banks RE; Selby PJ; Easton DF; Pharoah P; Andreotti G; Freeman LEB; Koutros S; Albanes D; Männistö S; Weinstein S; Clark PE; Edwards TL; Lipworth L; Gapstur SM; Stevens VL; Carol H; Freedman ML; Pomerantz MM; Cho E; Kraft P; Preston MA; Wilson KM; Michael Gaziano J; Sesso HD; Black A; Freedman ND; Huang WY; Anema JG; Kahnoski RJ; Lane BR; Noyes SL; Petillo D; Teh BT; Peters U; White E; Anderson GL; Johnson L; Luo J; Buring J; Lee IM; Chow WH; Moore LE; Wood C; Eisen T; Henrion M; Larkin J; Barman P; Leibovich BC; Choueiri TK; Mark Lathrop G; Rothman N; Deleuze JF; McKay JD; Parker AS; Wu X; Houlston RS; Brennan P; Chanock SJ
    Nat Commun; 2017 Jun; 8():15724. PubMed ID: 28598434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline polymorphisms in the Von Hippel-Lindau and Hypoxia-inducible factor 1-alpha genes, gene-environment and gene-gene interactions and renal cell cancer.
    van de Pol JAA; van den Brandt PA; van Engeland M; Godschalk RWL; van Schooten FJ; Hogervorst JGF; Schouten LJ
    Sci Rep; 2020 Jan; 10(1):137. PubMed ID: 31924838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal cell carcinoma risk is associated with the interactions of APOE, VHL and MTHFR gene polymorphisms.
    Lv C; Bai Z; Liu Z; Luo P; Zhang J
    Int J Clin Exp Pathol; 2015; 8(5):5781-6. PubMed ID: 26191297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA target site polymorphisms in the VHL-HIF1α pathway predict renal cell carcinoma risk.
    Wei H; Ke HL; Lin J; Shete S; Wood CG; Hildebrandt MA
    Mol Carcinog; 2014 Jan; 53(1):1-7. PubMed ID: 22517515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
    Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
    Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multilevel-analysis identify a cis-expression quantitative trait locus associated with risk of renal cell carcinoma.
    Shu X; Purdue MP; Ye Y; Wood CG; Chen M; Wang Z; Albanes D; Pu X; Huang M; Stevens VL; Diver WR; Gapstur SM; Virtamo J; Chow WH; Tannir NM; Dinney CP; Rothman N; Chanock SJ; Wu X
    Oncotarget; 2015 Feb; 6(6):4097-109. PubMed ID: 25784652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23.
    Wu X; Scelo G; Purdue MP; Rothman N; Johansson M; Ye Y; Wang Z; Zelenika D; Moore LE; Wood CG; Prokhortchouk E; Gaborieau V; Jacobs KB; Chow WH; Toro JR; Zaridze D; Lin J; Lubinski J; Trubicka J; Szeszenia-Dabrowska N; Lissowska J; Rudnai P; Fabianova E; Mates D; Jinga V; Bencko V; Slamova A; Holcatova I; Navratilova M; Janout V; Boffetta P; Colt JS; Davis FG; Schwartz KL; Banks RE; Selby PJ; Harnden P; Berg CD; Hsing AW; Grubb RL; Boeing H; Vineis P; Clavel-Chapelon F; Palli D; Tumino R; Krogh V; Panico S; Duell EJ; Quirós JR; Sanchez MJ; Navarro C; Ardanaz E; Dorronsoro M; Khaw KT; Allen NE; Bueno-de-Mesquita HB; Peeters PH; Trichopoulos D; Linseisen J; Ljungberg B; Overvad K; Tjønneland A; Romieu I; Riboli E; Stevens VL; Thun MJ; Diver WR; Gapstur SM; Pharoah PD; Easton DF; Albanes D; Virtamo J; Vatten L; Hveem K; Fletcher T; Koppova K; Cussenot O; Cancel-Tassin G; Benhamou S; Hildebrandt MA; Pu X; Foglio M; Lechner D; Hutchinson A; Yeager M; Fraumeni JF; Lathrop M; Skryabin KG; McKay JD; Gu J; Brennan P; Chanock SJ
    Hum Mol Genet; 2012 Jan; 21(2):456-62. PubMed ID: 22010048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation at the 8q24.21 renal cancer susceptibility locus affects HIF binding to a MYC enhancer.
    Grampp S; Platt JL; Lauer V; Salama R; Kranz F; Neumann VK; Wach S; Stöhr C; Hartmann A; Eckardt KU; Ratcliffe PJ; Mole DR; Schödel J
    Nat Commun; 2016 Oct; 7():13183. PubMed ID: 27774982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins.
    Rohan SM; Xiao Y; Liang Y; Dudas ME; Al-Ahmadie HA; Fine SW; Gopalan A; Reuter VE; Rosenblum MK; Russo P; Tickoo SK
    Mod Pathol; 2011 Sep; 24(9):1207-20. PubMed ID: 21602815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3.
    Purdue MP; Johansson M; Zelenika D; Toro JR; Scelo G; Moore LE; Prokhortchouk E; Wu X; Kiemeney LA; Gaborieau V; Jacobs KB; Chow WH; Zaridze D; Matveev V; Lubinski J; Trubicka J; Szeszenia-Dabrowska N; Lissowska J; Rudnai P; Fabianova E; Bucur A; Bencko V; Foretova L; Janout V; Boffetta P; Colt JS; Davis FG; Schwartz KL; Banks RE; Selby PJ; Harnden P; Berg CD; Hsing AW; Grubb RL; Boeing H; Vineis P; Clavel-Chapelon F; Palli D; Tumino R; Krogh V; Panico S; Duell EJ; Quirós JR; Sanchez MJ; Navarro C; Ardanaz E; Dorronsoro M; Khaw KT; Allen NE; Bueno-de-Mesquita HB; Peeters PH; Trichopoulos D; Linseisen J; Ljungberg B; Overvad K; Tjønneland A; Romieu I; Riboli E; Mukeria A; Shangina O; Stevens VL; Thun MJ; Diver WR; Gapstur SM; Pharoah PD; Easton DF; Albanes D; Weinstein SJ; Virtamo J; Vatten L; Hveem K; Njølstad I; Tell GS; Stoltenberg C; Kumar R; Koppova K; Cussenot O; Benhamou S; Oosterwijk E; Vermeulen SH; Aben KK; van der Marel SL; Ye Y; Wood CG; Pu X; Mazur AM; Boulygina ES; Chekanov NN; Foglio M; Lechner D; Gut I; Heath S; Blanche H; Hutchinson A; Thomas G; Wang Z; Yeager M; Fraumeni JF; Skryabin KG; McKay JD; Rothman N; Chanock SJ; Lathrop M; Brennan P
    Nat Genet; 2011 Jan; 43(1):60-5. PubMed ID: 21131975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in Tumor VHL Mutation and Hypoxia-inducible Factor 2α Expression Between African American and White Patients with Clear Cell Renal Cell Carcinoma.
    Callahan CL; Moore L; Lenz P; Linehan WM; Nickerson ML; Rothman N; Purdue MP
    Eur Urol; 2019 May; 75(5):882-884. PubMed ID: 30655088
    [No Abstract]   [Full Text] [Related]  

  • 15. The renal cancer risk allele at 14q24.2 activates a novel hypoxia-inducible transcription factor-binding enhancer of DPF3 expression.
    Protze J; Naas S; Krüger R; Stöhr C; Kraus A; Grampp S; Wiesener M; Schiffer M; Hartmann A; Wullich B; Schödel J
    J Biol Chem; 2022 Mar; 298(3):101699. PubMed ID: 35148991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
    Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
    Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two single nucleotide polymorphisms in the von Hippel-Lindau tumor suppressor gene in Taiwanese with renal cell carcinoma.
    Wang WC; Tsou MH; Chen HJ; Hsu WF; Lai YC
    BMC Res Notes; 2014 Sep; 7():638. PubMed ID: 25217002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex specific associations in genome wide association analysis of renal cell carcinoma.
    Laskar RS; Muller DC; Li P; Machiela MJ; Ye Y; Gaborieau V; Foll M; Hofmann JN; Colli L; Sampson JN; Wang Z; Bacq-Daian D; Boland A; Abedi-Ardekani B; Durand G; Le Calvez-Kelm F; Robinot N; Blanche H; Prokhortchouk E; Skryabin KG; Burdett L; Yeager M; Radojevic-Skodric S; Savic S; Foretova L; Holcatova I; Janout V; Mates D; Rascu S; Mukeria A; Zaridze D; Bencko V; Cybulski C; Fabianova E; Jinga V; Lissowska J; Lubinski J; Navratilova M; Rudnai P; Świątkowska B; Benhamou S; Cancel-Tassin G; Cussenot O; Trichopoulou A; Riboli E; Overvad K; Panico S; Ljungberg B; Sitaram RT; Giles GG; Milne RL; Severi G; Bruinsma F; Fletcher T; Koppova K; Larsson SC; Wolk A; Banks RE; Selby PJ; Easton DF; Pharoah P; Andreotti G; Beane Freeman LE; Koutros S; Albanes D; Männistö S; Weinstein S; Clark PE; Edwards TL; Lipworth L; Carol H; Freedman ML; Pomerantz MM; Cho E; Kraft P; Preston MA; Wilson KM; Michael Gaziano J; Sesso HD; Black A; Freedman ND; Huang WY; Anema JG; Kahnoski RJ; Lane BR; Noyes SL; Petillo D; Teh BT; Peters U; White E; Anderson GL; Johnson L; Luo J; Chow WH; Moore LE; Choueiri TK; Wood C; Johansson M; McKay JD; Brown KM; Rothman N; Lathrop MG; Deleuze JF; Wu X; Brennan P; Chanock SJ; Purdue MP; Scelo G
    Eur J Hum Genet; 2019 Oct; 27(10):1589-1598. PubMed ID: 31231134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline genetic variants in somatically significantly mutated genes in tumors are associated with renal cell carcinoma risk and outcome.
    Shu X; Gu J; Huang M; Tannir NM; Matin SF; Karam JA; Wood CG; Wu X; Ye Y
    Carcinogenesis; 2018 May; 39(6):752-757. PubMed ID: 29635281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Von Hippel-Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factors.
    Moore LE; Nickerson ML; Brennan P; Toro JR; Jaeger E; Rinsky J; Han SS; Zaridze D; Matveev V; Janout V; Kollarova H; Bencko V; Navratilova M; Szeszenia-Dabrowska N; Mates D; Schmidt LS; Lenz P; Karami S; Linehan WM; Merino M; Chanock S; Boffetta P; Chow WH; Waldman FM; Rothman N
    PLoS Genet; 2011 Oct; 7(10):e1002312. PubMed ID: 22022277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.